Antonios Tzortzakakis

Antonios Tzortzakakis

Affiliated to Research
Visiting address: Hälsovägen, Enheten för radiologi C1:46, 14186 Stockholm
Postal address: H9 Klinisk vetenskap, intervention och teknik, H9 CLINTEC Radiologi, 141 52 Huddinge
Part of:

About me

  • Antonios Tzortzakakis is a Senior Consultant in Radiology, Neuroradiology,
    and Nuclear Medicine at the Karolinska University Hospital, Huddinge,
    Stockholm, Sweden. He is responsible for the scientific research projects of
    the Nuclear Medicine Department at Karolinska University Hospital, Huddinge.

Research

  • Antonios Tzortzakakis's research interest focuses on Oncological Molecular
    Imaging in the era of Precision Medicine, the introduction of Theranostics,
    the integration of Radiomics, and Machine Learning with
    conventional/molecular imaging and other -omics, but also in the Molecular
    Imaging of Neurodegeneration. Antonios Tzortzakakis`s Ph.D. project examined
    the preoperative differentiation of renal oncocytomas from renal cell
    carcinomas using a 99mTc Sestamibi SPECT/CT. This new hybrid imaging method
    is now included in the Swedish National Guidelines concerning the
    preoperative examination of renal tumors.
    As deputy Principal Investigator in the First in Human study of a new
    radiotracer targeting Gastrin Releasing Peptide Receptors, namely
    68Ga-NOTA-PEG2-RM26 by means of PET/CT (EudraCT-nr 2021-004980-28) is
    supervising the examination of patients participating in the project. He is
    also responsible/co-ordinator for the following research studies in the
    Nuclear Medicine Department of Karolinska University Hospital, Huddinge:
    HER2-PET (EudraCT 2022-500448-39-00), and MIMIR-mTNBC trial (EudraCT
    2021-005603-12).